References
- Chung MJ. Urolithiasis and nephrolithiasis. JAAPA. 2017;30(9):49–50. doi:10.1097/01.JAA.0000522145.52305.aa
- Alexander RT, Hemmelgarn BR, Wiebe N, et al. Kidney stones and kidney function loss: a cohort study. BMJ. 2012;345:e5287. doi:10.1136/bmj.e5287
- Hsiao CY, Chen TH, Lee YC, et al. Urolithiasis is a risk factor for uroseptic shock and acute kidney injury in patients with urinary tract infection. Front Med. 2019;6:288. doi:10.3389/fmed.2019.00288
- Saigal CS, Joyce G, Timilsina AR, Urologic Diseases in America P. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808–1814. doi:10.1111/j.1523-1755.2005.00599.x
- Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3(1):18–26. doi:10.1016/j.euf.2017.04.001
- Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018;5(4):205–214. doi:10.1016/j.ajur.2018.08.007
- Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120(1):109–116. doi:10.1111/bju.13828
- Zeng Q, He Y. Age-specific prevalence of kidney stones in Chinese urban inhabitants. Urolithiasis. 2013;41(1):91–93. doi:10.1007/s00240-012-0520-0
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
- Liu S, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94(1):46–57. doi:10.2471/BLT.15.153148
- Cui F, Shen L, Li L, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi:10.3201/eid2305.161477
- Wang Z, Hu S, Sang S, Luo L, Yu C. Age-period-cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013. Stroke. 2017;48(2):271–275. doi:10.1161/STROKEAHA.116.015031
- Yuan S, Shi Y, Li M, Hu X, Bai R. Trends in incidence of urinary tract infection in Mainland China from 1990 to 2019. Int J Gen Med. 2021;14:1413–1420. doi:10.2147/IJGM.S305358
- Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296–2302. doi:10.1158/1055-9965.EPI-14-0300
- Cao J, Eshak ES, Liu K, Gero K, Liu Z, Yu C. Age-period-cohort analysis of stroke mortality attributable to high sodium intake in China and Japan. Stroke. 2019;50(7):1648–1654. doi:10.1161/STROKEAHA.118.024617
- Huang WY, Chen YF, Carter S, Chang HC, Lan CF, Huang KH. Epidemiology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study. J Urol. 2013;189(6):2158–2163. doi:10.1016/j.juro.2012.12.105
- Lee YH, Huang WC, Tsai JY, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int. 2002;68(3):172–177. doi:10.1159/000048445
- Xiao Y, Su C, Ouyang Y, Zhang B. Trends of vegetables and fruits consumption among Chinese adults aged 18 to 44 years old from 1991 to 2011. Chin J Epidemiol. 2015;36(3):232–236.
- Wang ZH, Zhang B, Wang HJ, et al. Trend in vegetable and fruit intake among Chinese children and adolescents aged 6 to 17 years from 1991 to 2009 and related socio-demographic factors. Chin J Epidemiol. 2013;34(9):863–868.
- Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–2259. doi:10.1681/ASN.2009030276
- Ngo TC, Assimos DG. Uric acid nephrolithiasis: recent progress and future directions. Rev Urol. 2007;9(1):17–27.
- Tsujihata M, Miyake O, Yoshimura K, Kakimoto KI, Takahara S, Okuyama A. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. J Urol. 2000;164(5):1718–1723. doi:10.1016/S0022-5347(05)67095-4
- Zhang NJ, Guo M, Zheng X. China: awakening giant developing solutions to population aging. Gerontologist. 2012;52(5):589–596. doi:10.1093/geront/gns105
- Howe N, Jackson R. Global aging and the crisis of the 2020s. Curr Hist. 2011;110(732):20–25. doi:10.1525/curh.2011.110.732.20
- Bai R, Wu W, Dong W, Liu J, Yang L, Lyu J. Forecasting the populations of overweight and obese Chinese adults. Diabetes Metab Syndr Obes. 2020;13:4849–4857. doi:10.2147/DMSO.S274110
- Iguchi M, Umekawa T, Katoh Y, Kohri K, Kurita T. Prevalence of urolithiasis in Kaizuka City, Japan--an epidemiologic study of urinary stones. Int J Urol. 1996;3(3):175–179. doi:10.1111/j.1442-2042.1996.tb00511.x
- Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71(2):209–213. doi:10.1016/j.urology.2007.09.034
- Hussein NS, Sadiq SM, Kamaliah MD, Norakmal AW, Gohar MN. Twenty-four-hour urine constituents in stone formers: a study from the northeast part of Peninsular Malaysia. Saudi J Kidney Dis Transpl. 2013;24(3):630–637. doi:10.4103/1319-2442.111090
- Yang J, Zhang Y, Luo L, Meng R, Yu C. Global mortality burden of cirrhosis and liver cancer attributable to injection drug use, 1990–2016: an age-period-cohort and spatial autocorrelation analysis. Int J Environ Res Public Health. 2018;15:1.
- Eisner BH, Goldfarb DS. A nomogram for the prediction of kidney stone recurrence. J Am Soc Nephrol. 2014;25(12):2685–2687. doi:10.1681/ASN.2014060631